OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Pathophysiology
Wolff-Parkinson-White (WPW) syndrome is a condition in which episodes of fast heart rate (called tachycardia) occur because of an abnormal extra electrical pathway in the heart. People with WPW may experience palpitations, dizziness, lightheadedness, and fainting, although some people with WPW have no symptoms.
Statistics
The prevalence rate for chronic Wolff-Parkinson-White syndrome has been estimated as 10% per 60,000.
Treatment
Medicines, particularly antiarrhythmic drugs such as procainamide or amiodarone, may be used to control or prevent a rapid heartbeat.
Major research
Researchers at the British Heart Foundation are working on several treatment options for Wolff-Parkinson-White syndrome.